Transient ischemic attack (TIA) market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.60% in the above mentioned forecast period.
Transient ischemic attack (TIA) is defined as a stroke that develops due to the blockage in blood flow to the brain. It occurs for short period of time as blood supply is restored quickly and prevents the death of brain tissue. It is caused due to blood clots that get trapped in the artery which supplies blood to the brain. It is characterised by tingling, dysphasia, weakness, dysarthria, confusion, vision changes, an altered level of consciousness, balance issues, headache, dizziness and an abnormal sense of taste and smell. This condition is also called mini stroke.
Rise in the prevalence of chronic disorders, cardiovascular diseases and neurological diseases, faulty dietary habits, and sedentary lifestyles are the major factors influencing the market growth rate. Furthermore, favorable reimbursement scenarios, growing demand for minimally invasive procedures and rising initiatives by government and private organizations to spread awareness about the disease and its available treatment are the factors that will expand the transient ischemic attack (TIA) market.
The rise in the investments for R&D activities by government organizations and technological advancement will provide beneficial opportunities for the transient ischemic attack (TIA) market in the forecast period of 2021-2028.
However, high cost of treatment and lack of awareness about the diagnosis and treatment of TIA are the factors that will hinder the market growth. Lack of skilled physicians will challenge the transient ischemic attack (TIA) market in the forecast period mentioned above.
Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/global-transient-ischemic-attack-tia-market
North America dominates the transient ischemic attack (TIA) market due to the presence of major key players, high disposable income and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The major players covered in the transient ischemic attack (TIA) market report are Abbott, Bayer AG, Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED., Boston Scientific Corp., electroCore, Inc., Cardinal Health, Cigna, Eli Lilly and Company, GENERAL ELECTRIC, LivaNova PLC, Medtronic, Merck KGaA, Novo Nordisk A/S, Siemens Healthcare GmbH, Stryker, Terumo Corporation, Zocere, Inc., Boehringer Ingelheim International GmbH., Johnson & Johnson Private Limited, and Bristol-Myers Squibb Company, among other domestic and global players.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Market Research Future has a half cooked research report on the global transient ischemic attack treatment market.Transient Ischemic Attack Treatment Market HighlightsTransient ischemic attack (TIA) are often called as mini-strokes.
A transient ischemic attack is considered to be a major warning sign of an impending future stroke.
Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.Global Transient Ischemic Attack Treatment Market is expected to grow at a CAGR of ~ 6.8 % during the forecast period 2017-2023.Increasing prevalence of neurological disorder like transient ischemic attack, epilepsy, rising need for better treatment, increasing investment of biotechnology and pharmaceutical industries in R, and availability of funds drive the growth of the market.
Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology will fuel the market growth during the forecast period.
The increasing focus of various government agencies on treating transient ischemic attack, epilepsy, depression, and heart attacks will have a positive impact on the growth of the market.
Japan holds the major share of the regional market due to availability of technology and huge healthcare spending.
Ischemic stroke market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – Global forecast till 2023Market Scenario:Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.
The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually.
As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.Avail a Free Sample Insights @ https://www.marketresearchfuture.com/sample_request/5423 The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and othersSegmentation:The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and othersOn the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomyOn the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.Browse Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423 Intended Audience:Ischemic Stroke Drug SuppliersIschemic Stroke Drug ManufacturersResearch and Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:Market Research Future +1 646 845 9312Email: [email protected]
